CAS: 125971-57-5; 2-Benzylidene-4-Methyl-3-Oxo-N-Phenylpentanamide

该化合物是有机化合物,其结构复杂,包括一个氯酮功能组和一个氨化物联系,其特点是五南化物主干柱,一个甲基组和一个苯甲基替代体,具有独特的化学特性;该苯基组的存在增强了其芳香特性,有可能影响其在有机溶剂中的再活性和溶解性;该克酮功能表明,它可能参与各种化学反应,如核生殖器添加或凝聚反应;此外,该化合物可能展示生物活动,从而引起对制药研究的兴趣;其分子结构表明,有可能与生物目标发生相互作用,可在药用化学领域加以探讨;总体而言,4-甲基-甲基三-氧-苯基-苯-2-苯基-2-苯甲基乙烯(苯基甲基苯基)聚胺是一种多种化合物,可用于有机合成和可能的治疗用途.

结构式图片

相似化合物

134430-88-9 125971-57-5 25775-89-7

欧盟法规

统一分类与标签REACH注册ECHA物质工作场所安全标识要求ECHA物质C&L通报REACH预注册废弃物危险特性清单

上下游产品

4-methyl-3-oxo-N-phenylpentanamide benzaldehyde aniline 3-amino propanoic acid 1,2-bis(4-fluorophenyl)-2-hydroxyethan-1-one 2-[2-(4-fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxopentanoic acid phenylamide (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid t-butyl ester tert-butyl (4R,6R)-6-{2-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]ethyl}-2,2-dimethyl-1,3-dioxane-4-acetate

合成工艺路线路线简述

    Isobutyrylacetic Acid置于哌啶,溶剂黄146,三乙胺体系中,用 正己烷,甲苯 用作溶剂,化学反应 4.0H,反应生成4-甲基-3-氧代-N-苯基-2-(苯甲烯基)戊酰胺
    参考文献:一种阿托伐他汀钙异构体的制备方法
    标题:一种阿托伐他汀钙异构体的制备方法
    摘要:本发明涉及了阿托伐他汀钙异构体[r‑(R*,R*)]‑2‑(3‑氟苯基)‑β,δ‑二羟基‑5‑(1‑甲基乙基)‑2‑苯基‑4‑[(苯胺基)羰基]‑1H‑吡咯‑1‑庚酸钙盐(简称imp‑1)与[r‑(R*,R*)]‑3‑(2‑氟苯基)‑β,δ‑二羟基‑5‑(1‑甲基乙基)‑3‑苯基‑4‑[(苯胺基)羰基]‑1H‑吡咯‑1‑庚酸钙盐(简称imp‑2)的制备方法.本发明提供了一种阿托伐他汀钙异构体的制备方法,为该药物的质量研究提供了对照品的制备方法,从而对阿托伐他汀钙的安全用药提供重要的指导意义.

    海关参考信息

    专利信息


    专利号:US-5998633-A
    优先权日:1996-07-29
    标 题:Process for the synthesis of protected esters of (S)-3,4-dihydroxybutyric acid
    发明人:JACKS THOMAS E; BUTLER DONALD E
    权利人:WARNER LAMBERT CO
    摘要:The invention is an improved process for the preparation of a compound of formula I wherein R and R 1 are each independently alkyl of from 1 to 3 carbon atoms; and R 2 is alkyl of from 1 to 8 carbon atoms. ##STR1##

    专利号:US-5155251-A
    优先权日:1991-10-11
    标题:Process for the synthesis of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate
    发明人:BUTLER DONALD E; LE TUNG V; MILLAR ALAN; NANNINGA THOMAS N
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of (5R)-1,1-dimethylethyl-6-cyano-5-hydroxy-3-oxo-hexanoate is described where a halo hydroxyester or other activated dihydroxyester is converted in two steps to the desired product.

    专利号:US-5248793-A
    优先权日:1990-10-17
    标 题:Process for the synthesis of (4R-cis)-1,1-dimethylethyl 6-iodomethyl or 6-(phenyl-substituted)sulfonyloxymethyl-2,2-dimethyl-1,3-dioxane-4-acetate
    发明人:MILLAR ALAN; BUTLER DONALD E
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of (4R-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate is described where a hydroxy ester derivative is converted in two steps to the desired product, as well as valuable intermediates used in the process.

    专利号:US-5103024-A
    优先权日:1990-10-17
    标题:Process for the synthesis of (4r-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate
    发明人:MILLAR ALLAN; BUTLER DONALD E
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of (4R-cis)-1,1-dimethylethyl 6-cyanomethyl-2,2-dimethyl-1,3-dioxane-4-acetate is described where a hydroxy ester derivative is converted in two steps to the desired product, as well as valuable intermediates used in the process.

    专利号:US-5280126-A
    优先权日:1988-02-22
    标题 :Process for trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
    发明人:BUTLER DONALD E; DEERING CARL F; MILLAR ALAN; NANNINGA THOMAS N; ROTH BRUCE D
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien-4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(±)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide by a novel synthesis where 4-methyl-3-oxo-N-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-α-[2-methyl-1-oxopropyl]-Y-oxo-N,β-diphenylbenzenebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.

    专利号:US-5216174-A
    优先权日:1988-02-22
    标题:Process for trans-6-[12-(substituted-pyrrol-1-yl)alkyl]pyran-2-one inhibitors of cholesterol synthesis
    发明人:BUTLER DONALD E; DEERING CARL F; MILLAR ALAN; NANNINGA THOMAS N; ROTH BRUCE D
    权利人:WARNER LAMBERT CO
    摘要:An improved process for the preparation of trans-6-[2-(substituted-pyrrol-1-yl)alkyl]pyran-2-ones by a novel synthesis is described where 1,6-heptadien4-ol is converted in eight operations to the desired products, as well as an improved process for the preparation of (2R-trans) and trans-(±)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1H-pyrrole-3carboxamide by a novel synthesis where 4-methyl-3-oxoN-phenylpentanamide is converted in eight operations to the desired product or alternatively 4-fluoro-α-[2methyl-1-oxopropyl]-γ-oxo-N,β-diphenylbenzenebutaneamide is converted in one step to the desired product, and additionally, a process for preparing (2R-trans)-5-(4-fluorophenyl)-2-(1-methylethyl)-N,4-diphenyl-1-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1Hpyrrole-3-carboxamide from (R)-4-cyano-3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]butanoic acid, as well as other valuable intermediates used in the processes.
    江西埃菲姆科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.afmpharm.com/
    电话: 793-33899567 13735087952👤
    📞江西埃菲姆科技有限公司 ⚠️参考联系方式

    销售电话:793-33899567 13735087952
    邮箱:sales@afmpharm.com
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别 ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    江西埃菲姆药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.afmpharm.com
    企业联系电话:0570-6040288👤
    📞江西埃菲姆药业有限公司 ⚠️参考联系方式
    联系人:董经理
    电话:0570-6040288
    手机:13320031450
    传真:86-570-6259526
    邮箱:sales@afmpharm.com
    通信地址: 江西省万年县石镇工业园区
    邮编: 324000
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:江西省万年县石镇工业园区
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页
    现货

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Kleemann, A.; Engel, J.; Kutscher, B.; Reichert, D., Pharmaceutical Substances[Online], Thieme: Stuttgart, (2006).
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知